Posted by Clinical Lab Products | Dec 15, 2009 | Cancer, Lung Cancer, Molecular Diagnostics |
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
Read MorePosted by Clinical Lab Products | Aug 28, 2009 | Cancer, Miscellaneous |
Abbott announced that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for the presence of gene rearrangements.
Read MorePosted by Clinical Lab Products | Apr 23, 2009 | Cancer, Miscellaneous |
Celera Corp announced the presentation of data describing a novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer.
Read MorePosted by Clinical Lab Products | Mar 13, 2009 | Cancer, Miscellaneous |
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read MorePosted by Clinical Lab Products | Mar 7, 2008 | Cancer, Lung Cancer, Molecular Diagnostics |
Abbott, Abbott Park, Ill, has inked an agreement with Genentech Inc, F Hoffmann-La Roche Ltd, and OSI Pharmaceuticals Inc to develop a gene test to potentially assess clinical benefits of an oral tablet for treating patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
Read More